Get your free ETF data sample from our comprehensive offerings. Start your free trial→
Help us improve your experience. Please confirm your investor type:
Compare ETFs Easily
The Ultimate ETF Comparison Tool - Try Now!
Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.
CHSRI ETF · UBS MSCI Switzerland IMI Socially Responsible ETF
The CHSRI Exchange Traded Fund (ETF) is provided by UBS. It is built to track an index: MSCI Switzerland IMI Extended SRI Low Carbon Select 5% Issuer Capped Index. The CHSRI ETF provides physical exposure, so by buying it you actually own parts of all the 54 underlying holdings. This share class generates a stream of income by distributing dividends.
Last update Today at 8:00 AM UTC
LIVE
CLOSED
This fund is part ofSwitzerland Blended Cap1M perf.-5.90%
Last price
CHF 18.47
1M perf.
-4.33%
1M flows
-€5.5M
AuM
€278M
E/R
0.28%
Rating
ESG Consensus®
CHSRI
CHF 18.47
Performance & flows
Segment for quartile rank
December 12, 2025 → March 12, 2026
Create a free account to view the flows graph
CHSRI
CHF 18.46
-0.41%
Switzerland Blended Cap
+1.92%
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | -4.33%  | -0.41%  | +1.85% | +27.60% | +24.48% | -7.37% | -2.73% | -2.73% | |
| Flows |
Key fund info
Segment for quartile rank
Main characteristics
More details
NAV
3/12/2026
CHF 18.43
1D NAV change
-0.18%
Dividend policy
Replication method
Direct (Physical)
Replication model
Full replication
No. of holdings
54
Inception date
9/11/2017
Jurisdiction
Switzerland
Distribution
Liechtenstein
Switzerland
Legal structure
Contractual Fund
Base currency
CHF
Dividend distribution
Trailing 12-month distr. yield
Distribution frequency
Last distribution
Create a free account to view dividend distribution
Classification
Product type
Benchmark
MSCI Switzerland IMI Extended SRI Low Carbon Select 5% Issuer Capped Index
Asset class
Factors
N/A
Investment strategy
The fund generally invests in Swiss large, mid and small cap stocks contained in the MSCI Switzerland IMI Extended SRI 5% Issuer Capped Index. The relative weightings of the companies correspond to their weightings in the index.
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
Built for professionals: access exclusive fund metrics and selection tools in Trackinsight Enterprise.
Enterprise Fund page features include:
Legal documents
Powerful buy-list integration
Fund data exports
Advanced risk metrics
Advanced replication analysis
Advanced exposure look-through
Upload your own internal metrics
Custom data feature
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSimilar ETFs
CHSRIA
1M perf.
-4.40%
E/R
0.28%
CHSR
1M perf.
-4.37%
E/R
0.28%
C030
1M perf.
-4.80%
E/R
0.25%
SLICHA
1M perf.
-4.47%
E/R
0.2%
DXS0
1M perf.
-4.56%
E/R
0.25%
Advertisement
Risk profile
Segment for quartile rank
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | -0.41% | +1.85% | +27.60%  | +24.48% |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
N/A
PRIIPS
1
2
3
4
5
6
7
Built for professionals: access exclusive risk metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseExposure
Countries
Switzerland
100.00%
Sectors
Health Care
28.12%
Financials
22.29%
Industrials
15.16%
Consumer Staples
8.21%
Materials
8.20%
Real Estate
2.69%
Communication Services
2.50%
Information Technology
1.77%
Unavailable
10.18%
Other
0.89%
Diversification
Total weight of top 15 holdings out of 54
Top 15 holdings
Data as of January 31, 2026
ROCHE
ABB
UBS GROUP AG
NOVARTIS
ZURICH INSURANCE
LONZA GRP AG
ALCON INC
NESTLE SA
Create a free account to view top holdings
GIVAUDAN
SWISS REINSURANCE
CH1243598427
SWISS LIFE
SIKA
CH1335392721
GEBERIT
Create a free account to view top holdings
Built for professionals: access exclusive exposure metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSustainability
Integrates ESG criteria
Yes
SDG
ESG Consensus® by Conser
Data as of December 31, 2025
MethodologyOur partner Conser gathers the industry's consensus on the business practices of the underlying holdings. We have computed the following metrics about CHSRI ETF's sustainability, based on their methodology.
ESG Consensus®
ESG Consensus® is based on the Final Sustainability Grade, which itself consists of 10 grades. Our partner Conser calculates the exact grade, based on market intelligence, using their proprietary ESG Consensus® methodology.
CHSRI’s has a Final Sustainability Grade of either A+, A, or A-.
A+
A
A-
B+
B
B-
C+
C
C-
D
This fund’s exact Final Sustainability Grade is available in Trackinsight Enterprise.
Learn more about Trackinsight EnterpriseHoldings review
96.06% of holdings have positive scoring
3.93% of holdings have negative scoring
61.22%
30.22%
Consensus levels
Strong
Medium
Weak
No data on remaining < 1% of holdings
Built for professionals: access exclusive sustainability metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseReplication
Trackinsight replication rating:
Replication quality
Calculated over 12m, as of February 27, 2026
Tracking error
Tracking difference
Replication information
Index
MSCI Switzerland IMI Extended SRI Low Carbon Select 5% Issuer Capped Net Total Return Index - CHF
Index ticker
NF734925 Index
Index dividend policy
NTR
Replication method
Replication model
Built for professionals: access exclusive replication metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseIssuer
UBS
UBS ID Card
Number of funds
447
Total AuM
€160.17B
Expense ratio range
0.03% - 0.95%
Average expense ratio
0.2379%
Top 5 funds by UBS
| AuM | ||
|---|---|---|
UETW | UBS Core MSCI World UCITS ETF | €7.34B |
AUUSI | UBS Gold ETF | €6.14B |
EMMUSC | UBS Core MSCI EM UCITS ETF | €5.61B |
EMUAA | UBS Core MSCI EMU UCITS ETF | €3.84B |
JPNA | UBS Core MSCI Japan UCITS ETF | €3.76B |
Frequently asked questions about CHSRI
What does UBS MSCI Switzerland IMI Socially Responsible ETF, CHSRI, invest in?
CHSRI is a Passive ETF. This ETF provides exposure to Other Swiss Equities.
Which benchmark or index does CHSRI replicate?
CHSRI tracks the MSCI Switzerland IMI Extended SRI Low Carbon Select 5% Issuer Capped Net Total Return Index - CHF, through a full replication replication method.
What is the Total Expense ratio (TER) of CHSRI?
CHSRI carries a total expense ratio (TER) of 0.28%, indicating the annual cost for holding the fund.
When was CHSRI launched?
CHSRI was introduced to the market on September 11, 2017. It trades on Liechtenstein, among other exchanges
Who is the ETF issuer of CHSRI?
UBS MSCI Switzerland IMI Socially Responsible ETF, CHSRI, is provided by UBS. Learn more about UBS here.
What is the current assets under management (AUM) of CHSRI?
CHSRI oversees €278M in assets as of March 12, 2026.
How has CHSRI performed lately?
Based on data from March 12, 2026, CHSRI returned -4.33% over the past month, -0.41% over the last three months and -2.73% year-to-date.
What are the latest inflows or outflows for CHSRI?
As of March 12, 2026, CHSRI recorded net flows of -€5.4M over the last month and -€12M year-to-date.
Does CHSRI distribute dividends?
CHSRI follows a distributing dividend policy, meaning it pays out income to investors. As of March 12, 2026, its 12-month trailing yield was 2.37%.
What are the main country or region exposures of CHSRI?
As of January 31, 2026, CHSRI has significant geographic allocations in Switzerland.
In which sector or theme does CHSRI invest in?
As of January 31, 2026, CHSRI focuses largely on Health Care, Financials and Industrials.
How many securities does CHSRI hold and how diversified is it?
As of January 31, 2026, CHSRI holds 54 positions in its portfolio, with 67.74% of assets concentrated in its top 15 holdings.
What are the main positions in CHSRI?
As of January 31, 2026, CHSRI top three holdings include ROCHE, ABB and UBS GROUP AG.
What is the base currency of CHSRI?
The base currency of CHSRI is CHF.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy | Cookie policy | | Terms of use | Imprint
Privacy policy | Cookie policy | | Terms of use | Imprint
